March 12, 2026

Semaglutide vs Tirzepatide (Ozempic vs Zepbound): Key Differences for Weight Loss & Blood Sugar

Semaglutide vs Tirzepatide (Ozempic vs Zepbound): Key Differences for Weight Loss & Blood Sugar
Apple Podcasts podcast player iconSpotify podcast player iconYoutube Music podcast player iconRSS Feed podcast player icon
Apple Podcasts podcast player iconSpotify podcast player iconYoutube Music podcast player iconRSS Feed podcast player icon

The Vagina Doctor Podcast with Duncan Turner MD

Sophie, a nurse practitioner at Turner Medical Arts, explains two main GLP-1 medications—semaglutide and tirzepatide—and how they differ. She describes semaglutide (Ozempic) as a GLP-1–only medication that slows gastric emptying to help people feel full faster, can cause constipation and nausea, and improves metabolic function by lowering blood sugars gradually, making it helpful for people with diabetes and weight to lose. She then outlines why tirzepatide (Zepbound) is her preferred option: it combines GLP-1 and GIP, with GIP receptors on fat cells that help target abdominal and visceral fat, leading to better weight loss and improved blood-sugar management, and it is better tolerated with fewer side effects.

00:00 Welcome to the Channel

00:30 GLP-1s Overview

00:58 Semaglutide Basics

01:31 Side Effects and Tolerance

01:44 Blood Sugar Benefits

02:26 Why Tirzepatide Wins

02:43 GIP and Fat Loss

03:19 Final Takeaways